David Anderson

David Anderson

Company: VBI Vaccines Inc.

Job title: Chief Scientific Officer


Role of a Vaccine Immunotherapeutic in Combination Therapy to Achieve Functional Cure for Chronic HBV Infection 10:00 am

In addition to current NUCs and next-generation therapies, consensus is building that a functional cure for chronic HBV will also require the use of an immunotherapeutic to break immunological tolerance and restore long-term immunologic control over the virus. VBI’s vaccine immunotherapeutic candidate, VBI-2601 has been designed to restore and enhance T cell & B-cell immunity…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.